Stock Events

Stock Events

Search...

iShares U.S. Pharmaceuticals

M$1,215

24

+M$0+0% Friday 13:37

Statistics

Day High

1,215

Day Low

1,215

52W High

3,318.86

52W Low

1,084

Volume

90

Avg. Volume

39

Mkt Cap

-

P/E Ratio

-

Dividend Yield

1.45%

Dividend

17.64

Upcoming

Dividend Payment

Dividend Payment

Dividend Payment

Dividend Payment

Dividend Payment

Dividends

1.45%Dividend Yield

10Y Growth

8.01%

5Y Growth

4.37%

3Y Growth

-4.41%

1Y Growth

16.41%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IHE.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Invesco Pharmaceuticals

PowerShares Dynamic Pharmaceuticals ETF, directly competes by investing in U.S. pharmaceutical companies.

SPDR Pharmaceuticals

SPDR S&P Pharmaceuticals ETF, tracks a similar S&P Pharmaceuticals Select Industry Index, making it a direct competitor.

Fidelity MSCI Health Care Index

Fidelity MSCI Health Care Index ETF, includes a significant allocation to pharmaceuticals, competing in the healthcare sector.

Vanguard Health Care

Vanguard Health Care ETF, has a broad exposure to the healthcare sector, including pharmaceuticals, making it a competitor.

iShares U.S. Healthcare

iShares U.S. Healthcare ETF, competes by investing in U.S. healthcare stocks, including pharmaceuticals.

Health Care Select Sector SPDR

Health Care Select Sector SPDR Fund, competes as it includes major pharmaceutical companies in its holdings.

VanEck Vectors Biotech ETF, while focused on biotech, it competes due to overlap in pharmaceuticals and healthcare.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF, competes indirectly through its focus on biotech, which includes companies involved in pharmaceuticals.

About

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

Show more...

CEO

ISIN

US4642888360

Listings